Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedRecruitment status has been updated to No longer looking for participants, and results have been posted. The page now includes new navigation sections and expanded location and timeline details, plus added study documents (Study Protocol and SAP).SummaryDifference3%

- Check8 days agoChange DetectedThe revision tag on the page has moved from v3.5.4 to v3.5.5, indicating a new version of the page has been published. This appears to be a minor metadata update rather than a substantive change to the trial information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision indicator was updated to v3.5.4, signaling a new revision of the study record.SummaryDifference0.0%

- Check37 days agoChange DetectedThe Collaborators section now lists 'GOG Foundation' as a collaborator, replacing the previous entry 'GOG Foundation, Inc. (GOG Foundation)'.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page footer has been updated to reflect a new ClinicalTrials.gov site release version (revision v3.5.3 instead of v3.5.0).SummaryDifference0.0%

- Check88 days agoChange DetectedLocation listing updated from Napoli, Italy to Naples, Italy to reflect English naming conventions. Study results status changed from No Results Posted to Results Submitted.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.